Extramedical Use of Prescription Pain Relievers by Youth Aged 12 to 21 Years in the United States
JAMA Pediatrics, 05/14/2012
Meier EA et al. – For initiatives to prevent youth from using prescription pain relievers to get high or for other unapproved indications, a focus on the last year of high school and the post–secondary school years may be too little too late. Practice–based approaches are needed in addition to public health interventions based on effective alcohol and tobacco prevention programs during the earlier adolescent years.
Cross-sectional surveys of adolescent cohorts, 2004 to 2008.
Large nationally representative samples of youth in the United States who had been assessed for the 2004 through 2008 National Survey on Drug Use and Health, yielding data from 138 729 participants aged 12 to 21 years.
The estimated peak risk of starting extramedical use of prescription pain relievers occurs in midadolescence, well before the college years.
The age at peak risk is 16 years, when an estimated 2% to 3% become newly incident users. Smaller risk estimates are observed at age 12 to 14 years and at age 19 to 21 years.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.